CoChat

Does recombinant human erythropoietin administration in critically ill COVID‐19 patients have miraculous therapeutic effects?

Open access
Hadadi, Azar, Mortezazadeh, Masoud, Kolahdouzan, Kasra, Alavian, Golbarg · 2020 · Journal of Medical Virology
Cited by 80

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

An 80‐year‐old man with multiple comorbidities presented to the emergency department with tachypnea, tachycardia, fever, and critically low O 2 saturation and definitive chest computerized tomography scan findings in favor of COVID‐19 and positive PCR results in 48 hours. He received antiviral treatment plus recombinant human erythropoietin (rhEPO) due to his severe anemia. After 7 days of treatment, he was discharged with miraculous improvement in his symptoms and hemoglobin level. We concluded that rhEPO could attenuate respiratory distress syndrome and confront the severe acute respiratory syndrome coronavirus 2 virus through multiple mechanisms including cytokine modulation, antiapoptotic effects, leukocyte release from bone marrow, and iron redistribution away from the intracellular virus.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/jmv.25839

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • Viral infection and iron metabolism

    Drakesmith, H., & Prentice, A. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1930 · Cited by 469

  • Iron and infection

    Ganz, T. (2018) · International Journal of Hematology · doi:10.1007/s12185-017-2366-2 · Cited by 270 · cited 1×

    “During inflammation, serum Hepcidin levels increase following stimulation by IL-6, downregulating cellular ferroportin and this leads to decreased iron absorption and its detainment in liver and spleen macrophages((12)) which could promote the survival of”
    Background

Cited by

See all 80

Metadata

Authors
Hadadi, A., Mortezazadeh, M., Kolahdouzan, K., & Alavian, G.
Venue
Journal of Medical Virology
Publisher
Wiley
Published
2020-04-19
Volume
92
Issue
7
Pages
915-918
ISSN
  • 0146-6615 (ISSN-L)
  • 1096-9071
OpenAlex
W3016053327
Cited by
80
References
2
FWCI
10.26
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.